Abstract:Background: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with a poor but heterogeneous prognosis. Although the ALS Functional Rating Scale (ALSFRS) has been most commonly used, the decreases in ALSFRS do not follow a unitary linear trend and may be affected by factors other than disease condition. Group-based trajectory modeling (GBTM) is a method that can take the heterogeneity of declines in ALSFRS into consideration. We analyzed the 16-year trajectory of ALSFRS of patients in China using the GBTM method, and explored possible reasons for differences in the trajectories.Methods: 3,257 patients with sporadic ALS from January 2005 to May 2021 were recruited. ALSFRS scores were the dependent variable in the GBTM. To evaluate whether our results were transferable to other populations, Answer ALS and Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) were used as validation datasets. The baseline characteristics and laboratory indicators in different trajectory groups were compared. A Cox proportional hazards model was used to examine the association between primary outcomes and trajectory groups.Results: A model with four groups (rapid, moderate, slow, and very slow progression) was adopted. The four groups differed in sex (P=0.002), age at onset (P<0.001), diagnostic delay (P<0.001), phenotype (P<0.001), riluzole use (P=0.001), onset site (P<0.001), cerebrospinal fluid (CSF) protein levels (P=0.044), and neutrophil-to-lymphocyte ratio (NLR; P=0.011). Compared with the moderate progression group, the rapid progression group displayed an increased risk of progression to respiratory insufficiency or death (hazard ratio [HR]: 1.66, 95% confidence interval [CI]: 1.41 to 1.97), but the very slow progression group (HR: 0.06, 95% CI: 0.02 to 0.26) had a decreased risk. The trajectory groups with faster progression had a higher NLR and higher total protein in the CSF.Interpretation: This study provides a novel prognosis prediction method using the ALSFRS score trajectory. Notably, the higher NLR and higher total protein in the CSF of the trajectory groups with faster progression suggested that neuroinflammation may play a crucial role in ALS progression.Funding Information: Lu Chen has received the funding from the Peking University Medicine Fund of Fostering Young Scholars’ Scientific & Technological Innovation supported by the Fundamental Research Funds for the Central Universities [Grant number BMU2022PY001]. Shengfeng Wang has received the funding from the Peking University Medicine Fund for World’s Leading Discipline or Discipline Cluster Development supported by the Fundamental Research Funds for the Central Universities [Grant number BMU2021YJ035]. Siyan Zhan has received the funding from the Special Project for Director, China Center for Evidence Based Traditional Chinese Medicine [Grant number 2020YJSZX-2]. Dongsheng Fan has received the fundings from the National Natural Science Foundation of China (NSFC) under Grant [Number 81873784; 82071426].Declaration of Interests: None.Ethics Approval Statement: The protocol was approved by the institutional ethics committee of PUTH (IRB. No 00006761), and written informed consent was obtained from each patient.

Trends in the Clinical Features of Amyotrophic Lateral Sclerosis: A 14‐year Chinese Cohort Study

Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China

Clinical and genetic characteristics of 1672 cases of amyotrophic lateral sclerosis in China: a single-center retrospective study

Epidemiology and factors predicting survival of amyotrophic lateral sclerosis in a large Chinese cohort

The Epidemiology and Genetics of Amyotrophic Lateral Sclerosis in China

Age at Onset of Amyotrophic Lateral Sclerosis in China

Long-Term Longitudinal Progression Pattern of Amyotrophic Lateral Sclerosis: A Trajectory Analysis of a 16-Year Cohort in China

Amyotrophic Lateral Sclerosis in Beijing: Epidemiologic Features and Prognosis from 2010 to 2015

Multicentre, prospective registry study of amyotrophic lateral sclerosis in mainland China (CHALSR): study protocol

Prognostic Factors in ALS: a Comparison Between Germany and China

Clinical features and progress in diagnosis and treatment of amyotrophic lateral sclerosis

Clinical Features and Cu/Zn Superoxide Dismutase Gene Mutations in Two Mainland Chinese Families with Amyotrophic Lateral Sclerosis

Clinical and genetic factors affecting diagnostic timeline of amyotrophic lateral sclerosis: a 15-year retrospective study

Incidence and Prevalence of Amyotrophic Lateral Sclerosis in Urban China: a National Population-Based Study

Hypothalamic Subregion Abnormalities Are Related to Body Mass Index in Patients with Sporadic Amyotrophic Lateral Sclerosis.

Clinical Determinants of Disease Progression in Amyotrophic Lateral Sclerosis—A Retrospective Cohort Study

Relationship between Clinical Characters and Onset Subtypes of Amyotrophic Lateral Sclerosis

Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis

Progress in clinical diagnosis of amyotrophic lateral sclerosis

Clinical characterization and founder effect analysis in Chinese amyotrophic lateral sclerosis patients with SOD1 common variants

A Natural History Comparison of SOD1-mutant Patients with Amyotrophic Lateral Sclerosis Between Chinese and German Populations